Xerafy Named Key Player in Surgical Instrument Tracking Systems Market

Data Bridge Market Research recognizes Xerafy’s technology as a leader in the $92.6 million global surgical instrument tracking market in its recent report. The research firm says the market reached $92.6 million (U.S. dollars) in 2016, and will experience a compound annual growth rate of 17.5% through 2024.

Surgical Tools On Stand With Doctors Operating Patient

Xerafy’s technology has a well-established reputation in the surgical instrument tracking solutions market,  powering instrument-level RFID tagging for both operating room (OR) and central sterile services department (CSSD) application environments. The company understands that hospitals must meet increasing regulatory requirements for accurate sterilization records, while keeping a keen focus on improving patient safety and reducing secondary infection rates, so using RFID for instrument counting and sterilization tracking can help save time in the operating theater while also ensuring that each medical device is properly sterilized. Xerafy’s RFID item-level approach is a vast improvement over previous tray-level solutions that rely on older technologies such as barcodes or laser etching.

Because RFID-based instrument tracking is still a relatively new concept at many healthcare facilities, Xerafy offers a demo kit to help hospitals get started. Xerafy’s RFID Instruments Tracking Demo Kit is designed to meet FDA UDI program requirements, providing process protection that can translate into significant cost savings while increasing efficiency and accuracy in instrument handling.

The demo kit includes 30 surgical instruments with autoclavable Xerafy XS tags attached, a surgical instrument tray with an attached Roswell tag, a handheld RFID reader, additional autoclavable tags, and Xerafy surgical instrument tracking demonstration software for iOS-based devices.

Join the conversation – What are the challenges you face when it comes to surgical instrument tracking in your hospital?

Leave a Reply

Your email address will not be published. Required fields are marked *